Pancreatic Cancer Research

ResearcherUniversity of Chicago Medical CenterNo recent work listed

Bo Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6668-671X; OpenAlex author ID A5101542985. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 4

  1. Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of the miR-506-3p/ZEB2/EMT axis Co-author DOI 10.21203/rs.3.rs-86053/v1↗
  2. Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway. Co-author DOI 10.1038/s41598-018-36214-5↗
  3. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.1007/s10620-017-4641-8↗
  4. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p. Co-author DOI 10.1016/j.bbrc.2016.11.120↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yeqing Zou · 3 shared papers, 2017–2020 · strength 0.28
  2. Xiaowei Fu · 2 shared papers, 2017–2020 · strength 0.20
  3. Xueqiang Deng · 1 shared paper, 2020 · strength 0.13
  4. Weidong Xiao · 1 shared paper, 2020 · strength 0.13
  5. Xiaozhong Wang · 1 shared paper, 2017 · strength 0.07
  6. Chuan Liu · 1 shared paper, 2017 · strength 0.07
  7. Zhiwei Zhong · 1 shared paper, 2017 · strength 0.07
  8. Bing Peng · 1 shared paper, 2018 · strength 0.06
  9. Tong‐Chuan He · 1 shared paper, 2018 · strength 0.06
  10. Xin Wang · 1 shared paper, 2018 · strength 0.06
  11. Xubao Liu · 1 shared paper, 2018 · strength 0.06
  12. Zhenyu Ye · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.